Evox Therapeutics (NASDAQ:EVOXW) Shares Up 3% – Should You Buy?

Evox Therapeutics plc (NASDAQ:EVOXW – Get Free Report) rose 3% during trading on Wednesday. The stock traded as high as $0.22 and last traded at $0.2060. 2,526 shares were traded during mid-day trading, a decline of 91% from the average daily volume of 29,616 shares. The stock had previously closed at $0.20.

Evox Therapeutics Stock Performance

The business has a 50-day moving average price of $0.28 and a two-hundred day moving average price of $0.37.

Evox Therapeutics is a biotechnology company focused on developing extracellular vesicles (EVs) as vehicles for delivering medicines. Its research centers on engineered exosomes, naturally occurring particles that can transport biological material between cells, with the goal of reaching tissues that can be difficult to target with conventional therapies. The company’s DeliverEX platform is designed to modify EVs for targeted delivery of therapeutic cargo, including RNA-based medicines and proteins.

Recommended Stories

Receive News & Ratings for Evox Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evox Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.